Align Technology, Inc. (ALGN)
158.64
-1.22
(-0.76%)
USD |
NASDAQ |
Sep 04, 16:00
158.54
-0.10
(-0.06%)
After-Hours: 20:00
Align Technology Research and Development Expense (Quarterly) : 102.03M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 102.03M |
| March 31, 2026 | 98.66M |
| December 31, 2025 | 83.04M |
| September 30, 2025 | 93.28M |
| June 30, 2025 | 96.40M |
| March 31, 2025 | 97.20M |
| December 31, 2024 | 94.88M |
| September 30, 2024 | 85.27M |
| June 30, 2024 | 92.19M |
| March 31, 2024 | 91.86M |
| December 31, 2023 | 82.16M |
| September 30, 2023 | 88.74M |
| June 30, 2023 | 88.48M |
| March 31, 2023 | 87.45M |
| December 31, 2022 | 83.52M |
| September 30, 2022 | 76.97M |
| June 30, 2022 | 72.96M |
| March 31, 2022 | 71.81M |
| December 31, 2021 | 72.48M |
| September 30, 2021 | 65.59M |
| June 30, 2021 | 57.72M |
| March 31, 2021 | 54.54M |
| December 31, 2020 | 48.89M |
| September 30, 2020 | 44.53M |
| June 30, 2020 | 40.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 41.53M |
| December 31, 2019 | 41.33M |
| September 30, 2019 | 39.68M |
| June 30, 2019 | 38.85M |
| March 31, 2019 | 37.50M |
| December 31, 2018 | 35.80M |
| September 30, 2018 | 32.70M |
| June 30, 2018 | 30.80M |
| March 31, 2018 | 29.59M |
| December 31, 2017 | 26.17M |
| September 30, 2017 | 24.20M |
| June 30, 2017 | 24.38M |
| March 31, 2017 | 22.80M |
| December 31, 2016 | 21.61M |
| September 30, 2016 | 20.42M |
| June 30, 2016 | 18.61M |
| March 31, 2016 | 15.08M |
| December 31, 2015 | 13.89M |
| September 30, 2015 | 17.78M |
| June 30, 2015 | 15.68M |
| March 31, 2015 | 13.88M |
| December 31, 2014 | 13.28M |
| September 30, 2014 | 12.85M |
| June 30, 2014 | 13.29M |
| March 31, 2014 | 13.38M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Dentsply Sirona, Inc. | 45.00M |
| Integra LifeSciences Holdings Corp. | 21.74M |
| Envista Holdings Corp. | 30.40M |
| Intuitive Surgical, Inc. | 370.40M |
| Boston Scientific Corp. | 554.00M |